Back

Cardiovascular toxicity profile of doxorubicin: data mining of the FDA adverse event reporting system (FAERS)

13 April 2024 (08:30 - 17:40)
Organised by: Logo
Congress Presentation Part of: Poster session 2 Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Lana Kattan

Qatar University, Doha (Qatar)

72 More presentations in this session

Presentation thumbnail
Characterization of senescence in human cardiac fibroblasts
Doctor A. Costa (Genoa, IT)
Abstract
Presentation thumbnail
Cardioprotective effect of cemtirestat treatment in male Zucker diabetic fatty rats: a pilot study.
Doctor T. Egan Benova (Bratislava, SK)
Abstract
Presentation thumbnail
Dynamic links between the cardiac intermediate filaments of the cytoskeleton and nucleoskeleton for proper cardiomyocyte differentiation, maturation and reprogramming.
Doctor M. Tsikitis (Athens, GR)
Abstract
Presentation thumbnail
Differential sex-dependent role of lncRNAs in cardiomyopathy
Professor D. Franco (Jaen, ES)
Abstract
Presentation thumbnail
MiR-92b-3p modulates apoptosis in smooth muscle cells through BCL2L11 regulation, unravelling novel therapeutic strategies for unstable plaques.
Mr J. Koester (Halle, DE)
Abstract

Access the full session

Session thumbnail
Poster session 2

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Unveiling doxorubicin-induced cardiotoxicity: into the heart with single-cell resolution
20 June 2025
thumbnail
Congress Presentation
Cardiovascular toxicities reported with Poly ADP Ribose Polymerase (PARP) inhibitors in the FDA Adverse Event Reporting System
21 June 2025
thumbnail
Congress Presentation
Cardiovascular toxicity prediction in breast cancer patients: the HFA/ICOS risk tool in real-world practice
21 June 2025
thumbnail
Congress Presentation
Cardiovascular toxicity following modern multiple myeloma therapy in Japanese cohort
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources